Blood pressure-lowering for prevention of major cardiovascular diseases in persons with and without type 2 diabetes

被引：0
作者：
Nazarzadeh, M. [1 ]
Rahimi, K. [1 ]
机构：
[1] Univ Oxford, Deep Med, NDWRH, Oxford, England
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷
关键词：
D O I：
10.1016/j.diabres.2022.109303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF21-0652
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes MellitusThe YESTONO Study
    Andre C. Schmidt
    Christine Graf
    Klara Brixius
    Juergen Scholze
    [J]. Clinical Drug Investigation, 2007, 27 : 841 - 849
  • [22] Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: The Yestono study
    Schmidt, Andre C.
    Graf, Christine
    Brixius, Klara
    Scholze, Juergen
    [J]. CLINICAL DRUG INVESTIGATION, 2007, 27 (12) : 841 - 849
  • [23] Racial/Ethnic Differences in the Use of Blood Pressure-Lowering Drugs Associated with Different Risk levels of Type 2 Diabetes among US Adults without Diabetes
    Shao, Hui
    Alkhuzam, Khalid
    Guo, Jingchuan
    Jiao, Tianze
    Smith, Steven M.
    Zhang, Ping
    Gregg, Edward W.
    [J]. DIABETES, 2022, 71
  • [24] Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis
    Xie, Wuxiang
    Zheng, Fanfan
    Evangelou, Evangelos
    Liu, Ou
    Yang, Zhenchun
    Chan, Queenie
    Elliott, Paul
    Wu, Yangfeng
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 (06) : 1256 - 1265
  • [25] Influences of Blood Pressure-Lowering Agents on Frailty Progression in Patients with Type 2 Diabetes: A Longitudinal Cohort Study
    Chao Chia-Ter
    Wang Jui
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [26] Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease
    Lonn, Eva M.
    Bosch, Jackie
    Lopez-Jaramillo, Patricio
    Zhu, Jun
    Liu, Lisheng
    Pais, Prem
    Diaz, Rafael
    Xavier, Denis
    Sliwa, Karen
    Dans, Antonio
    Avezum, Alvaro
    Piegas, Leopoldo S.
    Keltai, Katalin
    Keltai, Matyas
    Chazova, Irina
    Peters, Ron J. G.
    Held, Claes
    Yusoff, Khalid
    Lewis, Basil S.
    Jansky, Petr
    Parkhomenko, Alexander
    Khunti, Kamlesh
    Toff, William D.
    Reid, Christopher M.
    Varigos, John
    Leiter, Lawrence A.
    Molina, Dora I.
    McKelvie, Robert
    Pogue, Janice
    Wilkinson, Joanne
    Jung, Hyejung
    Dagenais, Gilles
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (21) : 2009 - 2020
  • [27] Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
    Wang, Ji-Guang
    Pimenta, Eduardo
    Chwallek, Frank
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 189 - 200
  • [28] Impact of blood pressure lowering in type 2 diabetes
    Richard J. Glassock
    George L. Bakris
    [J]. Nature Reviews Nephrology, 2015, 11 : 320 - 321
  • [29] Blood-pressure lowering in type 2 diabetes
    Gregory B. Lim
    [J]. Nature Reviews Cardiology, 2016, 13 (10) : 568 - 568
  • [30] Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key
    Bath, P
    [J]. STROKE, 2003, 34 (05) : 1334 - 1335
12345